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Abstract
Background: Validating non-contrast-enhanced computed tomography (nCT) compared to ultrasound sonography
(US) as screening method for abdominal aortic aneurysm (AAA) screening.
Methods: Consecutively attending men (n = 566) from the pilot study of the randomized Danish CardioVascular
Screening trial (DANCAVAS trial), underwent nCT and US examination. Diameters were measured in outer-to-outer
fashion. Sensitivity and specificity were done testing each modality against each other as reference standard.
Measurements were tested for correlation, variance in diameters, and mean differences were tested using paired t-test.
Results: Due to logistics, 533 underwent both nCT and US. In four patients, aortae could not be visualized with US, and
two of these had an AAA (>30 mm) as diagnosed by nCT. Using nCT 30 (5.7%, 95% CI: 4.2;7.5%) AAA were found. US
failed to detect 9 of these, but diagnosed 3 other cases, resulting prevalence by US was 4.5% (95% CI: 3.0;6.6%).
Additionally, 5 isolated iliac aneurysms (≥20 mm) (0.9%, 95% CI: 0.3;2.2%) were discovered by nCT.
US performed reasonably, with sensitivity ranging from 57.1–70.4%, specificity however, ranged higher 99.2–99.6%.
Comparably nCT performed with sensitivity ranging from 82.6–88.9%, nCTs specificity however ranged from 97.7–98.
4%. Analysis showed good correlations with no tendency to increasing variance with increasing diameter, and no
significant differences between nCT and US with means varying slightly in both axis.
Conclusions: nCT seems superior to US concerning sensitivity, and is able to detect aneurysmal lesions not detectable
with US. Finally, the prevalence of AAA in Denmark seems to remain relatively high, in this small pilot study group.
Background
Screening for abdominal aortic aneurysm (AAA) based
upon abdominal aortic ultrasound sonography (US) has
proven beneficial, cost-effective, which partly is the rea-
son why US-based screening programs have been imple-
mented in several countries [1–3]. However as reported
by the MASS trial [3], AAA related deaths do occur
years after screening programs finding normal aortas in
the attenders. This might be prevented by rescreening,
although intervals for rescreening in normal aortas have
yet to be established. Following this, the reduced AAA
specific mortality by screening is only about 50%, which
contrasts with reported attendance rates close to 80%
[4]. The specific causes are unknown - it could be, that
those in high risk do not attend, or down to false nega-
tive findings, incidental development, a combination, or
mistaken recorded cause of death.
Today two modalities are utilized to assess the infra-
renal aortic diameter (IAD) to diagnose AAA, namely
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US and computed tomography (CT), each with their
own benefits, and drawbacks.
As a screening modality for AAA, US has become ac-
cepted, because it is easy to operate, cheap and with an
estimated sensitivity and specificity close to 100% [5].
This however, was based upon the size distribution in
the population, and observed intervariation of US mea-
surements. In reality, US has never been validated as a
screening modality for AAA, it has only been validated
when AAA was present, and even when present with
significant interobserver variability [6–8]. Adding to this,
some infrarenal aortas are difficult to visualize due to in-
testinal gas and/or adiposity [9].
Using non-contrast CT scanning as an alternative
screening method for AAA might be more reliable, and
offer other screening potentials as coronary calcifica-
tions, thoracic- and iliac lesions. Because CT scanners
are becoming widely available and perform better with
each iteration, while using less radiation due to modern
iterative reconstruction algorithms, effectively enabling
CT to be a valid screening modality.
Contrast enhanced CT-scans are known to be more
precise, probably with 100% sensitivity and specificity,
but have not been tested as a screening tool. Addition-
ally, it would expose the examined individuals not only
for radiation, but potential nephrotoxic contrast. Con-
trast enhanced CT-scans are not widely available, time
consuming and thus expensive, making it a less rational
screening modality.
Nearly half the population in the Western world dies
due to cardiovascular diseases (CVD), mainly due to
ischemic heart disease. Focusing on traditionally risk
markers like hypertension, hypercholesterolemia and
diabetes screening and intervention have been tested in
randomized setups, and proven insufficient [10]. The
question is whether detection of asymptomatic arterial
lesions could lead to a better risk stratification and inter-
vention. Low dose non-contrast-enhanced cardiac CT
scan quantifying the degree of coronary arterial calcifica-
tion, and has been proven to be one of the best predic-
tors of future cardiac events [11, 12], and might be the
tool for future screening and intervention. If such a scan
is expanded to include the chest and abdomen, thoracic
as well as abdominal aortic aneurysms would be ex-
posed, but the question is whether infrarenal aorta will
be sufficiently visualized. This question arises from the
modern low dosage scans used in cardiac CT which
might not visualize the infrarenal aorta sufficiently.
Consequently, in the pilot study of the randomized
Danish CardioVascular Screening trial (DANCAVAS
trial) men underwent screening for AAA by both US
and non-contrast-enhanced CT scanning (nCT) [13, 14].
The aim of this study, is to validate nCT as a comparable
modality to US in a AAA screening setting.
Methods
Design
Population based cross-sectional study within a popula-
tion based multicenter randomized screening trial. All
Danish citizens are given a unique civil registration
number at birth, with which we are able to track all their
interactions with the Danish health institutions (e.g. hos-
pital admissions, drug prescriptions etc.). Through this
registry 45.000 men will be randomly selected based on
their age, and geographic location, to correspond to our
screening sites. A third of the selected men will be in-
vited to our cardiovascular screening program, whilst
the remaining two thirds will be followed through the
registries. There are no exclusion criteria for the partici-
pants in this study. This article will only be analyzing
data from primary attenders the pilot study, consisting
of 956 invitees, of which 566 attended primarily.
Participants
The DANCAVAS trial is an ongoing multicenter trial
with Danish screening sites in Odense, Svendborg,
Vejle and Silkeborg. Ethical approval was obtained by
the Southern Denmark Region Committee on Bio-
medical Research Ethics (S-20140028) and the Data
Protection Agency, and registered in ISRCTN (DOI
10.1186/ISRCTN12157806) [13]. The study protocol
was reviewed and approved by the institutional review
board, all participants were given written and oral in-
formation about the study, and written consent was
obtained from each participant.
The primary aim is to investigate whether combined
advanced cardiovascular screening will prevent death
and cardiovascular events, and whether the likely health
benefits are cost effective.
One-third of 45.000 will be invited a screening ex-
aminations at one of the 4 locations. The screening
will include: (1) nCT scan to detect coronary artery
calcification above the corresponding age median,
and aortic/iliac aneurysms, (2) Brachial and ankle
blood pressure index to detect peripheral arterial
disease and hypertension, (3) an assessment of the
CT monitored heart rhythm to detected atrial fibril-
lation, and (4) a measurement of the cholesterol and
plasma glucose levels. Up-to-date cardiovascular pre-
ventive treatment is recommended in case of positive
finding. Positive AAA findings is defined as infra
renal aortic diameter ≥30 mm, and iliac aneurysms
are defined as ≥20 mm.
In Odense, men aged 65–74 were consecutively invited
to participate in the DANCAVAS pilot screening pro-
gram in the autumn 2014, with no exclusion criteria. In
total, 956 were invited and 566 attended initially when
this validation study took place.
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Imaging
Medical students, received training by an experienced
vascular surgeon, before being allowed to evaluate par-
ticipants used a GE Logiq E9 with a C1-5-D or C1-6-D
transducer to perform all ultrasound abdominal aortic
measurements. Using the cinematic function, the max-
imal systolic outer-to-outer diameter was measured in
the anterior-posterior (AP) and transverse plane [15, 16].
The US examinations were blinded to the results from
the nCT examinations carried out consecutively, and
vice versa.
Low dose nCT were performed with a Siemens Soma-
tom Definition Flash: spiral scan with a pitch of 3.2
(Flash), 100 kV tube voltage, 90 mAs, collimation of 128
x 0.6 mm, Safire 3 and slice thickness 5 mm from the
thoracic aorta, to the common femoral arteries. Trained
radiographers, using Siemens Syngo.via, evaluated the
resulting CT-images. In case of an obvious aneurysm,
the diameters were measured outer to outer, measure-
ments were in the axis of the aorta for both AP/trans-
verse planes. In case of no aneurysms the outer to outer
dimensions of the abdominal aorta was measured in a
transversal and an anterior-posterior plane just above
the bifurcation of the aorta. Diameters of the iliac arter-
ies were noted in case of aneurysm.
Statistical analysis
Data was initially merged in a 2x2 table (Tables 1A-C)
and sensitivity and specificity was calculated, using each
method as reference standard for the other. Sensitivity
and specificity as well as predictive values are presented
in percentages for ease of interpretation, their confi-
dence intervals are ‘exact’ Clopper-Pearson confidence
intervals.
The data was mainly analyzed as suggested by Bland
and Altman [17]. First data was examined for normal-
distribution, this was found to be true, although diameters
slightly shifted to the left graphically. Secondly, data were
examined by plotting the results from nCT against US.
Systematic differences between the two methods were
tested by paired t-test. Statistical analysis was carried out
using SPSS 22 (IBM Corp. Released 2013. IBM SPSS Sta-
tistics for Windows, Version 22.0. Armonk, NY: IBM
Corp.) and Stata 14 (StataCorp. 2015. Stata Statistical
Software: Release 14. College Station, TX: StataCorp LP.).
Results
Visibility and prevalence
533 men, mean age 69.4 years ±2.51 (1SD), underwent
both nCT and US, additionally 4 (0.7%) of these were
Table 1 A-C, Title: Cross tabulation of results used for sensitivity calculations
Legend: US/CT AP – 0 denotes an AP diameter of <30 mm; 1 denotes an AP diameter of >30 mm
US/CT Trans - 0 denotes a Transverse diameter of <30 mm; 1 denotes a Transverse diameter of >30 mm
US/CT AAA – 0 denotes any US measurements <30 mm; 1 denotes any measured diameter >30 mm
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unable to be assessed satisfyingly by US, due to adiposity
and/or intestinal gas, these were excluded from the cal-
culations completely. Two of the 4 US invisible cases
had an AAA diagnosed by nCT sized 32 mm and
42 mm, respectively. Consequently, 529 underwent both
nCT and US. Thirty AAA were discovered using nCT,
resulting in an occurrence of 5.7% (95% CI: 4.2;7.5%).
US failed to identify 9 of these aneurysms, which were
measured to be 27.4–42.8 mm in AP and 27.3–40.5 mm
in the transverse plane with nCT (Fig. 1a and b).
US diagnosed 24 AAA (4.5% (95% CI: 3.0;6.6%)), 3
of which were not identified by nCT, these were
found to be 30.2–31.8 mm in AP plane and 19.8–
44.6 mm in the transverse plane using US, these were
however measured by nCT to range from 18.3–
19.7 mm in both planes (Fig. 2).
Unfortunately, the US examinations were not stored,
but the CT scans were. Two senior consultants reexa-
mined the nCT scans of the 12 conflicting findings
blinded by knowledge of which test modality was used
to diagnose the aneurysm. They uniformly classified all
the 9 cases only diagnosed by nCT as AAA, and none of
the 3 AAA diagnosed by US scans.
In addition, 5 isolated iliac aneurysms (≥20 mm)
(0.9%, 95% C.I.: 0.3;2.2%) were discovered by nCT, −
none of these were discovered by US, which were also
validated by senior consultants.
Sensitivity, and specificity and predictive values
Each modality was used as a reference standard for the
other to analyze sensitivity and specificity respectively.
Iliac aneurysms were not included as positive findings,
when calculating sensitivity and specificity.
US performed with a modest sensitivity ranging from
57.1% (95% C.I.: 37.2;75.5%) to 70.4% (95% C.I.:
49.8;86.3%), with high specificity ranging from 99.2% (95%
C.I.: 97.9;99.8%) to 99.6% (95% C.I.: 98.6;99.9%) (Table 2).
nCT performed better with a sensitivity ranging from
82.6% (95% C.I.: 61.2;95.1%) to 88.9% (95% C.I.:
65.3;98.6%). Concerning specificity, nCT fared compar-
ably to US with a specificity of 97.7% (95% C.I.:
95.9;98.8%) to 98.4% (95% C.I.: 96.9;99.3%) (Table 3).
Expert review in those cases where US found an
aneurysm, and nCT however did not, resulted in nCT
sensitivity of 100% (95% C.I: 88.4;100%) and equally with
a specificity of 100% (95% C.I: 99.3;100%).
Analysis of discrepancies concerning diameter
Comparing all measurements including AAA, mean di-
ameters in CTap and USap measurements show means of
21.3 and 21.2 mm respectively, with standard deviations
of 5.3 and 5.0 (paired mean difference −0.05 ± −3.16
(SD), p = 0.70). The same applies for the measurements
for the transverse plane showing CTtrans and UStrans
means of 21.6 and 21.3 mm respectively, along with
Fig. 1 a Shows AAA measured 41.6 mm and a.iliaca aneurisms
measuring 21.1 mm. b False Negative US finding, was measured
to be 25.7 mm in the transverse with US, however nCT measured it
was found to be 40.5 mm
Fig. 2 Transverse measurement done with CT was 19.7 mm, US
grossly overestimated this at 44.6 mm. It should be mentioned that
the participant in question was obese, making US examination troubling
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standard deviations of 5.5 and 5.1 (paired mean differ-
ence −0.28 ± −3.67 (SD), p = 0.08).
Pearson’s correlation analysis of the measured diam-
eter by the two modalities showed good agreement
concerning AP measurement (Rho = 0.81, p < 0.0001)
and to a close extent concerning transverse measure-
ments (Rho = 0.75, p < 0.0001) (Fig. 3a and b). Bland-
Altman plots [14] presenting the difference vs. the
mean of the measured diameter in both planes
showed apparently, no tendency to increasing differ-
ence with increasing diameter in either planes (Fig. 4a
and b). However, Pearson’s correlation analysis of the
difference versus the mean diameter was r = 0.114 (p
= 0.0088) concerning AP measurements, and r = 0.083
(p = 0.0569) concerning transverse diameter indicating
a minor increasing difference by increasing maximal
aortic diameter in both planes.
Comparing mean AAA diameters in CTap and USap
measurements show means of 38.1 and 34.7 mm respect-
ively, with standard deviations of 9.7 and 10.5 (paired
mean difference −3.3 ± 5.8 (SD), p = 0.004). The same ap-
plies for the measurements for the transverse plane show-
ing CTtrans and UStrans means of 38.6 and 34.2 mm
respectively, along with standard deviations of 9.5 and 9.9
(paired mean difference −4.39 ± 8.17 (SD), p = 0.006).
Pearson correlation analysis of the measured diameter by
the two modalities showed only a modest agreement con-
cerning AP (r = 0.7508, p < 0.0001) and transverse mea-
surements (Rho = 0.7008, p < 0.0001). Pearson correlation
analysis of the difference versus the mean diameter was
Rho = 0.1853 (p < 0.0001) and r = 0.1203 (p = 0.0055) con-
cerning AP and transverse diameter, respectively. Bland-
Altman plots examining the recorded AAA cases, showed
increased difference between the used modalities with in-
creasing diameters (Fig. 5a and b).
Discussion
This is the first direct comparison of screening for AAA
with non-contrast CT versus US. nCT was found to have
superior sensitivity compared to US, and similar specifi-
city. Our study is hampered by the lack of a real refer-
ence modality such as contrast CT, or contrast MRi.
However, this was not included in the primary protocol
because of the lack of feasibility to include such a mo-
dality. It was therefore decided that the modalities would
be held up against each other, as reference standards,
since neither had been validated as a AAA screening
modality.
This study shows that in a screening setting, nCT has
improved sensitivity over US. However, there is still a
great deal of clinical evidence favoring US as a method,
due to the reduced costs availability, and high specificity.
When aorta is visible utilizing US, it showed reason-
able sensitivity for US with nCT being superior over US.
Both modalities had a comparable high specificity. In
addition, isolated iliac aneurysms are not likely to be de-
tected by US, because AAA screening does not include
the iliac arteries when using US. Consequently, as a
screening tool for AAA, nCT seems acceptably valid,
which is coherent with our hypothesis. In addition, it
adds to the shortcomings of current AAA screening pro-
grams, because it is able to include the iliac arteries as
well. Whether it too is acceptable as part of a
multifaceted screening offer, we cannot conclude, as
re-invitations, and final attendance rates are not yet
available. It should be noted, that the pilot study was
troubled by some preventable mishaps, with random
lacking ultra sound devices, and not being able to review
the US images being the most important issues. How-
ever, these issues would probably not have changed the
final results of this study, but are worth mentioning.
Table 2 Sensitivity, Specificity and predictive values when US compared to nCT as reference standard CT
Sensitivity 95% CI Specificity 95% CI PV+ 95% CI PV- 95% CI
AP 0.7037 0.5;0.86 0.9920 0.98;0.99 0.8261 0.68;0.97 0.9841 0.68;0.97
Trans 0.5714 0.37;0.76 0.9960 0.99;0.99 0.8889 0.65;0.98 0.9765 0.96;0.99
AAA 0.7000 0.51;0.85 0.9940 0.98;0.99 0.8750 0.68;0.97 0.9821 0.97;0.99
For each measured plane, the sensitivity and specificity values and their corresponding 95% CI interval is presented. Additionally, positive and negative predictive
values are included, with their 95% CI interval
AP: Cases are participants with a anterior posterior mesurement of >30 mm
TRANS: Cases are participants with a transverse measurement of >30 mm
AAA: Cases are particpants with measurement in any plane of >30 mm
Table 3 Sensitivity, Specificity and predictive values when CT compared to US as reference standarda
SENSITIVITY 95% CI SPECIFICITY 95% CI PV+ 95% CI PV- 95% CI
AP 0.8261 0.61;0.95 0.9841 0.97;0.99 0.7037 0.5;0.86 0.9920 0.98;0.99
TRANS 0.8889 0.65;0.99 0.9765 0.96;0.99 0.5714 0.37;0.76 0.9960 0.99;0.99
AAA 0.8750 0.68;0.97 0.9821 0.97;0.99 0.7000 0.51;0.85 0.9940 0.98;0.99
aAP : Cases are participants with a anterior posterior mesurement of >30 mm
TRANS: Cases are participants with a transverse measurement of >30 mm
AAA: Cases are particpants with measurement in any plane of >30 mm
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A possible limitation of this study is the lack of a
truly accurate reference standard, which in this case
would be 3D contrast enhanced CT scans, but this
was not feasible nor ethically responsible to include.
Only men were invited to participate in this study, and
this could be argued as a limitation, however, men are at
increased risk solely because of their gender why a car-
diovascular screening program would be targeted at
men. However, a subgroup of women will be invited, to
evaluate the potential cost-benefit of expanding the
screening program to include women.
Although, nCT showed a comparable specificity to US,
we cannot conclude that this should be the reference
standard for screening for AAA as it is not widely avail-
able causing longer travel distances with assumable
lower attendance, is time consuming and thus expensive.
Nevertheless, nCT was able to detect more AAA (preva-
lence 5.7% versus 4.5%) and iliac aneurysms compared
to US. This could – at least partially – explain the rela-
tively low reduction in aneurysm related death in US-
based randomized screening trials. nCT may thus be
more efficient and perhaps a cost-effective alternative in
a screening scenario, this however requires more data
than currently available. This is especially true if re-
peated US scans are required to improve sensitivity to a
comparable level of CT, since only one repetition of a
US scan, closes the cost-gap between US and CT.
The medical students were trained in US, but have not
undergone the same magnitude of screening as ultra-
sonographers and other health care personnel conduct-
ing AAA screening. On the other hand, equipment with
better-quality resolution, than portable scanners can
offer was used. IAD was measured outer-to-outer, to be
comparable to the UK screening program which also
measures IAD in this fashion. The majority (7 of 9) of
the AAA not detected by US but having visible aortas
were found to be ectatic (>25 mm), while two were nor-
mal < 25 mm. These might have been detected by later
5-year interval, if introduced, since half of ectatic cases
develop true AAA within 5 years [2]. This is due to true
incidental cases or false negative findings. Those de-
tected as ectatic by US but positive with nCT may be
false positives, this could question whether rescreening
five years after non-contrast screening will be beneficial
[18]. However, they hardly make out the 50% reported to
Fig. 3 a, Correlation of all AP measurements. X-axis show the mean
CT AP measurements. Y-axis show mean US AP measurements. b,
Correlation of all Transverse measurements. X-axis show the mean
CT transverse measurements. Y-axis show mean US transverse
measurements
Fig. 4 a, Title: Bland Altman Plot for AP measurements. x-axis represents
the aortic measurements size, with the y-axis presenting the difference
of measurements between the utilized modalities. Legend: Diamond :
Classified as AAA by nCT not by US. Square: Both classified as AAA.
Triangle: classified by US as AAA only. b, Title: Bland Altman Plot for
transverse measurements. x-axis represents the aortic measurements size,
with the y-axis presenting the difference of measurements between the
utilized modalities. Legend: Diamond : Classified as AAA by nCT not by
US. Square: Both classified as AAA. Triangle: classified by US as AAA only
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develop an AAA in this subgroup of the male population
[2]. Consequently, DANCAVAS will re-invite this group
after five years. Additionally, it could be argued that the
3 cases found by US and not by nCT, are actually false
positives, thus making nCT appear less precise than it
essentially is.
While US is an acceptable screening modality, it does
have some shortcomings, mainly patients with a large
waist circumference or intestinal gas diameters become
difficult to asses properly, there are of course certain
maneuvers to improve the assessment, but in a screen-
ing scenario these are not feasible.
We theorized that calcification would improve the val-
idity of the non-contrast CT, but have not recorded any
aortic calcification quantification. Consequently, we used
two indirect signs of calcification as the coronary artery
calcification score and ankle brachial index. The coron-
ary artery calcification score correlated significantly posi-
tively with the difference of the measurements. However,
this could be due to confounding from a clear positive
correlation between coronary artery calcification score
and waist circumference, as the other indirect calcifica-
tion marker, lowest measured ankle brachial index, did
not correlate with the observed differences.
As an epidemiological sub finding, this study also gave
a modern estimate on the prevalence of AAA in
Denmark in men, which does not seem to decline as re-
ported in UK and Sweden [19]. The prevalence of AAA
in Denmark remains relatively high. US based prevalence
on Fyn (DANCAVAS 2014) is almost similar to the
prevalence of 4.2% detected in the Viborg County
(1994–98) [20] and higher than the prevalence of 3.3%
detected in the VIVA trial (2008–11) in the Mid region
of Denmark [21]. However, it should be noted that this
is a small sample, and as the DANCAVAS trial con-
tinues, the AAA prevalence will be reported with in-
creased certainty.
Using low dose nCT for screening purposes will ul-
timately result, in increased radiation exposure to
those participating. However, screening for AAA is a
one-time event, which in combination with the ad-
vances made with modern CT-scanners reduces this
risk greatly, making the risk negligible in these elderly
males [22]. Thus, making nCT a worthwhile modality,
since it allows for a more thorough CVD screening
than US does, while not inducing illnesses. Addition-
ally, there may be incidental findings further improv-
ing disease prevention, this however would require
the participant’s approval. This was not a part of this
study, however, if a suspicious found was made by ac-
cident, the participant was informed and referred to
the relevant specialties.
It is worth noting, that there is a secondary benefit to
a reliable screening method, because of the psychological
impact a false positive or negative result will have on the
participant. This is especially important, when screening
for common and potentially lethal diseases.
Conclusions
Low-dose nCT scanning seems to be more sensitive than
US, screening for AAA, making it a possible tool for a
larger scale screening program.
Expanding the screening to not only include AAA but
also generally for CVDs, nCT may become truly benefi-
cial, because it enables evaluations of the aortic and iliac
vessels in their entire length, as well as evaluating any
arcane lesions to the coronary arteries, thus providing
more information about the patient’s possible risks –
this however requires additional research.
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